Trials / Completed
CompletedNCT02670863
Safety and Efficacy Study
Safety and Efficacy of a New Term Infant Formula Supplemented With A Prebiotic: a Doubleblind, Randomized, Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 239 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 21 Days – 26 Days
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of the experimental formula supplemented with a prebiotic vs the control formula.
Detailed description
Randomized, double-blind, controlled interventional clinical trial design. The purpose of this study is to evaluate the safety and efficacy of a new term infant formula supplemented with a prebiotic vs a standard infant formula fed for 150 days to healthy, term infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental Infant Formula | Standard bovine milk-based term infant formula supplemented with a prebiotic, fed ad libitum |
| OTHER | Standard Infant Formula | Standard bovine milk-based term infant formula, fed ad libitum |
Timeline
- Start date
- 2016-01-21
- Primary completion
- 2017-03-01
- Completion
- 2017-05-01
- First posted
- 2016-02-02
- Last updated
- 2021-10-11
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT02670863. Inclusion in this directory is not an endorsement.